H.C. Wainwright Reiterates Buy Rating on Compass Therapeutics (CMPX)

Go back to H.C. Wainwright Reiterates Buy Rating on Compass Therapeutics (CMPX)
(NASDAQ: CMPX) Delayed: 2.14 +0.07 (3.38%)
Previous Close $2.07    52 Week High
Open $2.11    52 Week Low
Day High $2.23    P/E N/A 
Day Low $2.09    EPS
Volume 2,391,282